UC San Francisco news release
A new study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.
To investigate it, the team compared blood samples and fat biopsies from 46 people living with well-controlled HIV to those from 74 people without HIV. None of the participants were obese or had diabetes.
The researchers found that the people with HIV had more fibrosis, or scarring, in their fat tissues, and this was associated with insulin resistance — a key predictor of type 2 diabetes. This fibrosis was obvious in HIV patients no matter their body weight or the specific kinds of HIV medications they were taking.
Read the full news release here.
Source : EurekAlert!
Related HIV and Co-Infections News
-
McGill University Health Centre: Liver disease and HIV: Study reveals major gaps in liver fibrosis screening and offers a promising solution
-
[AIDS 2026] aidsmap: Returning to HIV care does not erase the effects of treatment interruption, studies show
-
[AIDS 2026] City St George’s, University of London: Risk of death 21% lower in people with HIV-related fungal disease given combination drug treatment
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.